Kit For The Preparation Of Technetium Tc 99m Medronate Injection, Powder, Lyophilized, For Solution
Product Images NDC 65857-505

2 FDA label images from Cardinal Health 414, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Kit For The Preparation Of Technetium Tc 99m Medronate (NDC 65857-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 414, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Medronic Acid (Image 01)

Structure Of Medronic Acid (Image 01)
Chemical structure of technetium Tc 99m medronate, showing two phosphonate groups connected by an ethane backbone with hydroxyl groups and double-bonded oxygens.*
FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
Packaging label for Kit for the Preparation of Technetium Tc 99m Medronate injection, powder, lyophilized for solution by Cardinal Health 414, LLC. The label includes storage instructions, contents description listing 10 sterile multi-dose reaction vials and 20 radioactivity labels, and a barcode. The product is nonradioactive and intended for intravenous use after radiolabeling with sodium pertechnetate Tc 99m.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.